title: Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation.
abstract: BACKGROUND
  Arginine methylation by protein N-arginine methyltransferases (PRMTs) is an important posttranslational modification in the regulation of protein signaling. PRMT2 contains a highly conserved catalytic Ado-Met binding domain, but the enzymatic function of PRMT2 with respect to methylation is unknown. The JAK-STAT pathway is proposed to be regulated through direct arginine methylation of STAT transcription factors, and STAT3 signaling is known to be required for leptin regulation of energy balance.
  
  
  OBJECTIVE
  To identify the potential role of STAT3 arginine methylation by PRMT2 in the regulation of leptin signaling and energy homeostasis.
  
  
  RESULTS
  We identified that PRMT2(-/-) mice are hypophagic, lean, and have significantly reduced serum leptin levels. This lean phenotype is accompanied by resistance to food-dependent obesity and an increased sensitivity to exogenous leptin administration. PRMT2 colocalizes with STAT3 in hypothalamic nuclei, where it binds and methylates STAT3 through its Ado-Met binding domain. In vitro studies further clarified that the Ado-Met binding domain of PRMT2 induces STAT3 methylation at the Arg31 residue. Absence of PRMT2 results in decreased methylation and prolonged tyrosine phosphorylation of hypothalamic STAT3, which was associated with increased expression of hypothalamic proopiomelanocortin following leptin stimulation.
  
  
  CONCLUSIONS
  These data elucidate a molecular pathway that directly links arginine methylation of STAT3 by PRMT2 to the regulation of leptin signaling, suggesting a potential role for PRMT2 antagonism in the treatment of obesity and obesity-related syndromes.
authors.affiliation: Brigham and Women's Hospital, 75 Francis St, PB408, Boston, MA 02115, USA.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Iwasaki
authors.forename: Jason C
authors.initials: JC
authors.lastname: Kovacic
authors.forename: Michelle
authors.initials: M
authors.lastname: Olive
authors.forename: Jeanette K
authors.initials: JK
authors.lastname: Beers
authors.forename: Takanobu
authors.initials: T
authors.lastname: Yoshimoto
authors.forename: Martin F
authors.initials: MF
authors.lastname: Crook
authors.forename: Leonardo H
authors.initials: LH
authors.lastname: Tonelli
authors.forename: Elizabeth G
authors.initials: EG
authors.lastname: Nabel
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D001835:Body Weight / Q000502:physiology; D004435:Eating / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D006003:Glycogen / Q000378:metabolism; D020738:Leptin / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008745:Methylation; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008817:Mice, Mutant Strains; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology; D010766:Phosphorylation / Q000502:physiology; D017434:Protein Structure, Tertiary; D011484:Protein-Arginine N-Methyltransferases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D020738:Leptin; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D006003:Glycogen; D008780:Methyltransferases; C553397:PRMT2 protein, mouse; D011484:Protein-Arginine N-Methyltransferases; C464934:protein arginine methyltransferase 2
references.citation: Genomics. 1998 Mar 15;48(3):330-40
references.pmid: 9545638
references.citation: Nature. 2003 Feb 20;421(6925):856-9
references.pmid: 12594516
references.citation: J Cell Sci. 2009 Mar 1;122(Pt 5):667-77
references.pmid: 19208762
references.citation: Nature. 1997 Jan 9;385(6612):165-8
references.pmid: 8990120
references.citation: Neuron. 1998 Dec;21(6):1375-85
references.pmid: 9883730
references.citation: J Neurosci. 1998 Jan 1;18(1):559-72
references.pmid: 9412531
references.citation: Cell. 2001 Mar 9;104(5):731-41
references.pmid: 11257227
references.citation: Neuron. 1999 Aug;23(4):775-86
references.pmid: 10482243
references.citation: Mol Endocrinol. 2008 Mar;22(3):751-9
references.pmid: 18096691
references.citation: Endocrinology. 2007 Jan;148(1):72-80
references.pmid: 17023536
references.citation: Neuroendocrinology. 1998 Dec;68(6):420-7
references.pmid: 9873206
references.citation: Mol Cell Biol. 2002 Aug;22(16):5662-8
references.pmid: 12138178
references.citation: Science. 1999 Jun 25;284(5423):2174-7
references.pmid: 10381882
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4661-6
references.pmid: 15070774
references.citation: J Nutr. 2003 Jul;133(7):2244-9
references.pmid: 12840187
references.citation: J Biol Chem. 2002 Sep 27;277(39):35787-90
references.pmid: 12171910
references.citation: Mol Cell Biol. 2006 May;26(10):3864-74
references.pmid: 16648481
references.citation: Dev Cell. 2002 Apr;2(4):497-503
references.pmid: 11970899
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4695-700
references.pmid: 15070780
references.citation: Exp Cell Res. 2006 Jul 1;312(11):2040-53
references.pmid: 16616919
references.citation: Biochem J. 2001 Sep 1;358(Pt 2):305-14
references.pmid: 11513728
references.citation: Neuron. 1999 Sep;24(1):155-63
references.pmid: 10677034
references.citation: Biochem J. 2009 Jun 26;421(2):253-61
references.pmid: 19405910
references.citation: Mol Cell Endocrinol. 2002 Sep 30;195(1-2):109-18
references.pmid: 12354677
references.citation: J Virol. 2001 Sep;75(17):8031-44
references.pmid: 11483748
references.citation: Nat Med. 1999 Sep;5(9):1066-70
references.pmid: 10470087
references.citation: J Steroid Biochem Mol Biol. 2007 Oct;107(1-2):1-14
references.pmid: 17587566
references.citation: Science. 1999 Mar 5;283(5407):1544-8
references.pmid: 10066179
references.citation: J Biol Chem. 2002 Aug 9;277(32):28624-30
references.pmid: 12039952
references.citation: Science. 1995 Jul 28;269(5223):540-3
references.pmid: 7624776
references.citation: J Immunol. 2004 Jun 1;172(11):6744-50
references.pmid: 15153491
references.citation: Mamm Genome. 1997 Jul;8(7):526-9
references.pmid: 9196002
references.citation: Nat Genet. 1996 Sep;14(1):95-7
references.pmid: 8782827
references.citation: J Clin Invest. 2000 Dec;106(11):1417-25
references.pmid: 11104795
references.citation: J Clin Invest. 2000 Jun;105(12):1827-32
references.pmid: 10862798
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):499-503
references.pmid: 1731319
references.citation: J Neurosci. 2009 Sep 16;29(37):11582-93
references.pmid: 19759305
references.citation: J Mol Endocrinol. 2005 Apr;34(2):339-51
references.pmid: 15821101
references.citation: Mol Cell Biol. 1996 Sep;16(9):4932-41
references.pmid: 8756652
references.citation: J Biol Chem. 2000 May 12;275(19):14563-72
references.pmid: 10799542
references.citation: J Biol Chem. 2002 Nov 1;277(44):41547-55
references.pmid: 12196522
references.citation: Nature. 2001 May 24;411(6836):480-4
references.pmid: 11373681